CV CapsoVision: רווח נקי למניה ב-12 החודשים האחרונים

CapsoVision Inc (CV) has fully outsourced the production of its capsules to external EMS contractors, focusing exclusively on research and development and patents. This EPS (TTM) chart demonstrates a value of 0.00, which correlates with the expansion of cloud-based GI imaging analysis services. The business relies on contract electronics manufacturing and international logistics services to support specialized medical centers.

A conservative approach requires price growth to be validated by a real increase in earnings. This indicator measures the daily change in net income over the last twelve months relative to the same period last year. By analyzing the year-over-year EPS growth dynamics over a rolling period, one can assess the resilience of CapsoVision Inc (CV) to external shocks. Stable demand for endoscopic capsules minimizes the risk of drawdowns, confirming the high reliability of the company's investment profile.